Molecular tumor board guides treatment in advanced sarcoma but benefits few patients
A retrospective study of 125 advanced sarcoma patients found molecular tumor board recommendations led to treatment in 32.8 percent, with ...
A retrospective study of 125 advanced sarcoma patients found molecular tumor board recommendations led to treatment in 32.8 percent, with ...
A Nature Reviews Cancer review argues that theranostics should expand beyond radiolabelled peptides to include nanotheranostics, microtheranostics and imaging-guided surgery.
A microfluidic platform called GradientScreen generates overlapping drug gradients and its combination response metrics correlate with minimal residual disease and ...
A new review details how the pan-RAS inhibitor daraxonrasib doubled overall survival in a phase III pancreatic cancer trial and ...
A new open-access review maps how stem cell-derived extracellular vesicles could serve as dual therapeutic and diagnostic tools in precision ...
A systematic analytical review maps how ultra-sensitive biosensors and programmable nanorobotic platforms are being combined into closed-loop cancer theranostic systems, ...
A review in Discover Oncology describes how the gut microbiota can modulate chemotherapy efficacy and resistance through drug sequestration, metabolic ...
A new study shows that the choice between Wnt-based and OncoPro culture medium reshapes the transcriptional state and drug sensitivity ...
A case report documents 35 months of oral ivosidenib therapy with partial remission and no adverse events in a man ...
A prospective trial found constitutional pathogenic variants in about 10 percent of solid tumor patients screened through comprehensive cancer genome ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine